Last $65.56 USD
Change Today +1.78 / 2.79%
Volume 1.3M
DGX On Other Exchanges
Symbol
Exchange
New York
Stuttgart
As of 4:15 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

3 Giralda Farms

Madison, NJ 07940

United States

Phone: 973-520-2700

Fax:

nge of pharmaceutical, biotechnology, and medical device companies. Life Insurer Services The company provides risk assessment services to the life insurance industry in North America. It also provides risk assessment services for insurance companies doing business outside North America. The company’s risk assessment services comprise underwriting support services to the life insurance industry, including data gathering, paramedical examinations, and clinical laboratory testing. The laboratory tests that the company performs and data that it gathers are designed to assist insurance companies objectively to evaluate the mortality risks of applicants. Majority of its specimen collections and paramedical examinations are performed by its network of approximately 5,500 paramedical examiners at the applicant's home or workplace. The company also offers paramedical examinations through approximately 600 of its patient service centers, and operates approximately 80 locations other than patient service centers in North America where it provides paramedical examinations, bringing the total number of sites in North America where the company could provide these examinations to approximately 680. It also contracts with third parties to coordinate providing these exams at approximately 350 additional locations worldwide. Diagnostic Products Focus Diagnostics and Celera Corporation (Celera) develop and manufacture products that enable healthcare professionals to make healthcare diagnoses, including products for testing for the professional market. The company offers these products in the United States, and through distributors, in other countries. Focus Diagnostics develops, manufactures, and markets diagnostic products, which could be performed on various instrument platforms. Focus Diagnostics' product lines include Simplexa molecular chemistries with a focus on infectious disease and hospital-acquired infections, HerpeSelect HSV serology, and a line of DxSelect IFA and ELISA products for testing for emerging infectious diseases. Focus Diagnostics maintains a global distribution agreement with 3M Corporation to bring real-time polymerase chain reaction products to the market using Simplexa molecular chemistries and the 3M Integrated Cycler, an instrument. Focus Diagnostics sells its diagnostic products to academic medical centers, hospitals, and commercial laboratories. Celera offers various molecular diagnostic products in segments, such as HIV-1 drug resistance testing (under the ViroSeq brand), reproductive genetics, and transplantation (under the Atria and AlleleSeqr brands). Celera products are sold to a spectrum of customers. Healthcare Information Technology The company provides interoperable technologies that help healthcare organizations and physicians enter, share, and access clinical information without information technology implementation or workflow disruption. The company’s Care360 EHR product allows physicians to generate a record of a clinical patient encounter; automates and streamlines the clinician's workflow; and allows for deployment and implementation with minimal workflow disruption. The solution allows doctors to electronically create, manage, and distribute patient encounter notes, including vital signs and progress notes. It captures lab and radiology results, provides clinical decision support tools and allows doctors to send secure messages and clinical information to other practitioners and secure, Web-based laboratory results to their patients' personal health records. ChartMaxx is the company’s electronic document management system for hospitals. Clients have contracted for its use at approximately 185 sites nationwide. Customers and Payers The company’s customers and payers include physicians, health insurance plans, IDNs, employers, pharmaceutical companies, and others. Its third-party payers include health insurance plans, self-insured employer benefit funds, accountable care organizations, patient-centered medical homes, the traditional Medicare or Medicaid program, physicians, or others (a hospital, another laboratory or an employer). The company also provide

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DGX:US $65.56 USD +1.78

DGX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cepheid $53.95 USD +4.16
Covance Inc $103.52 USD +0.91
Hologic Inc $26.96 USD +0.59
Laboratory Corp of America Holdings $106.44 USD +2.88
QIAGEN NV €19.05 EUR +0.75
View Industry Companies
 

Industry Analysis

DGX

Industry Average

Valuation DGX Industry Range
Price/Earnings 18.3x
Price/Sales 1.3x
Price/Book 2.2x
Price/Cash Flow 15.4x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QUEST DIAGNOSTICS INC, please visit www.questdiagnostics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.